Company Filing History:
1 out of 5,094 
1 out of 96 
Years Active: 2012
Title: The Innovative Contributions of Marc Spielmann
Introduction
Marc Spielmann is a notable inventor based in Cachan, France. He has made significant contributions to the field of molecular diagnostics, particularly in the diagnosis of breast cancer. His innovative approach utilizes advanced polynucleotide probe sets to enhance the accuracy of cancer detection.
Latest Patents
Marc Spielmann holds a patent for a groundbreaking invention titled "Molecular in vitro diagnosis of breast cancer." This invention involves the use of multiple polynucleotide probe sets, each designed to specifically hybridize with genes and their variants. The technology aims to determine the expression variations of at least 12 genes, facilitating the diagnosis of whether a breast tumor is benign or malignant. He has 1 patent to his name.
Career Highlights
Throughout his career, Marc Spielmann has worked with prestigious institutions, including the Centre National de la Recherche Scientifique and the Institut Gustave Roussy. His work in these organizations has contributed to advancements in cancer research and diagnostics.
Collaborations
Marc has collaborated with esteemed colleagues such as Fabrice Andre and Stefan Michiels. These partnerships have furthered his research and innovation in the field of molecular diagnostics.
Conclusion
Marc Spielmann's contributions to the field of breast cancer diagnosis through his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the lives of many, showcasing the importance of innovation in healthcare.